184 related articles for article (PubMed ID: 32665351)
21. Knowledge, attitudes, and practices among Saudi women regarding cervical cancer, human papillomavirus (HPV) and corresponding vaccine.
Jradi H; Bawazir A
Vaccine; 2019 Jan; 37(3):530-537. PubMed ID: 30503079
[TBL] [Abstract][Full Text] [Related]
22. Understanding Patients' Perspectives and Information Needs Following a Positive Home Human Papillomavirus Self-Sampling Kit Result.
Tiro JA; Betts AC; Kimbel K; Buist DSM; Mao C; Gao H; Shulman L; Malone C; Beatty T; Lin J; Thayer C; Miglioretti DL; Winer RL
J Womens Health (Larchmt); 2019 Mar; 28(3):384-392. PubMed ID: 30481121
[TBL] [Abstract][Full Text] [Related]
23. Social and psychological impact of HPV testing in cervical screening: a qualitative study.
McCaffery K; Waller J; Nazroo J; Wardle J
Sex Transm Infect; 2006 Apr; 82(2):169-74. PubMed ID: 16581749
[TBL] [Abstract][Full Text] [Related]
24. Impact of HPV sample self-collection for underscreened women in the renewed Cervical Screening Program.
Smith M; Lew JB; Simms K; Canfell K
Med J Aust; 2016 Mar; 204(5):1941e-7. PubMed ID: 26985849
[TBL] [Abstract][Full Text] [Related]
25. A Qualitative Exploration of Women's Experiences with a Community Health Volunteer-Led Cervical Cancer Educational Module in Migori County, Kenya.
Choi Y; Oketch SY; Adewumi K; Bukusi E; Huchko MJ
J Cancer Educ; 2020 Feb; 35(1):36-43. PubMed ID: 30368651
[TBL] [Abstract][Full Text] [Related]
26. Correlates of women's intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval.
Ogilvie GS; Smith LW; van Niekerk D; Khurshed F; Pedersen HN; Taylor D; Thomson K; Greene SB; Babich SM; Franco EL; Coldman AJ
BMC Public Health; 2016 Mar; 16():213. PubMed ID: 26935960
[TBL] [Abstract][Full Text] [Related]
27. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
Wong EL; Cheung AW; Wong AY; Chan PK
Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
[No Abstract] [Full Text] [Related]
28. HPV primary cervical screening in England: Women's awareness and attitudes.
Patel H; Moss EL; Sherman SM
Psychooncology; 2018 Jun; 27(6):1559-1564. PubMed ID: 29521462
[TBL] [Abstract][Full Text] [Related]
29. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
Lilliecreutz C; Karlsson H; Spetz Holm AC
PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
[TBL] [Abstract][Full Text] [Related]
30. No longer recommended for cervical screening: How women aged 18-24 feel about the renewed National Cervical Screening Program.
Jegathees S; Mac OA; Dodd RH
Aust N Z J Obstet Gynaecol; 2021 Aug; 61(4):576-584. PubMed ID: 33861463
[TBL] [Abstract][Full Text] [Related]
31. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
32. 'I'm here to save my life': a qualitative study of experiences navigating a cryotherapy referral system for human papillomavirus-positive women in western Kenya.
Huchko M; Adewumi K; Oketch S; Saduma I; Bukusi E
BMJ Open; 2019 Jul; 9(7):e028669. PubMed ID: 31345973
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis.
Tatar O; Thompson E; Naz A; Perez S; Shapiro GK; Wade K; Zimet G; Gilca V; Janda M; Kahn J; Daley E; Rosberger Z
Prev Med; 2018 Nov; 116():40-50. PubMed ID: 30172799
[TBL] [Abstract][Full Text] [Related]
34. A Qualitative Study of Parental Knowledge and Perceptions of Human Papillomavirus and Cervical Cancer Prevention in Rural Central Java, Indonesia: Understanding Community Readiness for Prevention Interventions.
Spagnoletti BRM; Bennett LR; Wahdi AE; Wilopo SA; Keenan CA
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2429-2434. PubMed ID: 31450917
[TBL] [Abstract][Full Text] [Related]
35. The projected timeframe until cervical cancer elimination in Australia: a modelling study.
Hall MT; Simms KT; Lew JB; Smith MA; Brotherton JM; Saville M; Frazer IH; Canfell K
Lancet Public Health; 2019 Jan; 4(1):e19-e27. PubMed ID: 30291040
[TBL] [Abstract][Full Text] [Related]
36. Exploring the psychosexual impact and disclosure experiences of women testing positive for high-risk cervical human papillomavirus.
Bennett KF; Waller J; Bailey JV; Marlow LAV
Br J Health Psychol; 2023 Feb; 28(1):62-79. PubMed ID: 35819012
[TBL] [Abstract][Full Text] [Related]
37. Influences on human papillomavirus (HPV)-related information needs among women having HPV tests for follow-up of abnormal cervical cytology.
O'Connor M; Costello L; Murphy J; Prendiville W; Martin CM; O'Leary JJ; Sharp L;
J Fam Plann Reprod Health Care; 2015 Apr; 41(2):134-41. PubMed ID: 25248873
[TBL] [Abstract][Full Text] [Related]
38. Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening.
Papa D; Moore Simas TA; Reynolds M; Melnitsky H
J Low Genit Tract Dis; 2009 Apr; 13(2):66-71. PubMed ID: 19387125
[TBL] [Abstract][Full Text] [Related]
39. Cervical cancer prevention in Australia: Planning for the future.
Saville AM
Cancer Cytopathol; 2016 Apr; 124(4):235-40. PubMed ID: 26619381
[TBL] [Abstract][Full Text] [Related]
40. Knowledge and experience of a cohort of HIV-positive and HIV-negative Ghanaian women after undergoing human papillomavirus and cervical cancer screening.
Stuart A; Obiri-Yeboah D; Adu-Sarkodie Y; Hayfron-Benjamin A; Akorsu AD; Mayaud P
BMC Womens Health; 2019 Oct; 19(1):123. PubMed ID: 31647013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
